Medicaid substitution rules prevent CHIP from replacing affordable private insurance, but how they're applied varies by state. Some require 90-day waits; others use automated systems. Learn how states handle this complex rule - and what it means for families.
Big pharma uses legal tricks like product hopping and REMS abuse to block cheaper generic drugs. Courts are split, but the FTC is fighting back. Here’s how these tactics cost billions-and what’s being done to stop them.
Learn how to accurately share your over-the-counter meds and supplement use with your healthcare provider to prevent dangerous interactions. Get practical steps, real examples, and expert-backed advice.
Drug prices vary wildly around the world - a pill can cost $5 in Australia and $300 in the U.S. This article breaks down why, how different countries control costs, and what it means for patients.
Discover how to find the real price of generic medications using tools like GoodRx, RTBTs, and state portals. Learn why prices vary and how to save money on prescriptions today.
Facial flushing from medications is a common side effect caused by drugs that dilate blood vessels. Learn which medications trigger it, how to reduce the redness, and when to seek help.
Not all drugs have authorized generics - even when patents expire. Learn why big pharma chooses when to launch them, how they affect pricing, and what this means for your prescription costs.
Cold sores and pimples look similar but have different causes and treatments. Learn how to tell them apart, what triggers them, and how to treat each one correctly to avoid spreading infection or worsening your skin.
Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, encouraging development of drugs that would otherwise be too costly to produce. Here's how it works, who benefits, and why it's changing.
Natural disasters like hurricanes and floods are causing life-threatening drug shortages across the U.S. From IV fluids to insulin, climate risks are exposing dangerous gaps in pharmaceutical supply chains - and the system isn't ready.